Dr. Donna Reece MD, FRCPC
Director, Program for Multiple Myeloma and Related Diseases
Princess Margaret Cancer Centre
Professor of Medicine
University of Toronto
Dr. Reece is Professor of Medicine at the University of Toronto and Director of the Program for Multiple Myeloma and Related Diseases in the Department of Medical Oncology and Hematology at Princess Margaret Hospital. She holds the Molly and David Bloom Chair in Multiple Myeloma Research and is Chair of the Multiple Myeloma Clinical Trials Group of the National Cancer Institute of Canada. Dr. Reece also serves on the Myeloma Canada Scientific Advisory Board and leads the Myeloma Canada Research Network. She earned her medical degree from Baylor College in Houston, Texas. She completed an internship in internal medicine at the University of Colorado Affiliated Hospitals, her residency in internal medicine at the Jewish Hospital in St. Louis, Missouri, and a fellowship in hematology and oncology at the Barnes Hospital, Washington University in St. Louis, Missouri. Her research interests include hematopoietic stem cell transplantation, lymphoid malignancies, and plasma cell dyscrasias.
Dr. Laurie Sehn MD, FRCPC
B.C. Cancer Agency
Clinical Assistant Professor
University of British Columbia
Dr. Sehn is a Clinical Assistant Professor at the B.C. Cancer Agency and the University of British Columbia in Vancouver. She has been a medical oncologist and clinical investigator with the Lymphoma Tumour Group since 1998. Dr. Sehn has served on the Board of Directors of Lymphoma Canada since 2002 and is now Director of Research Fellowships for Lymphoma Canada. Her research interests include the lymphoid cancers, with particular focus on the biology and treatment of large-cell lymphoma, the application of new imaging techniques such as PET scanning to lymphoma management, and innovative new approaches to treatment.
Dr. Joseph Connors MD, FRCPC
Clinical Director and Medical Oncologist
B.C. Cancer Agency
University of British Columbia
Dr. Connors earned his medical degree from Yale University. He completed his residency training in Internal Medicine and chief residency at the University of North Carolina in Chapel Hill. Prior to completing his Medical Oncology Fellowship at Stanford University, he worked at the Indian Health Service in Alaska for two years. In 1981, he accepted a position in Medical Oncology at the B.C. Cancer Agency. He has been a member of the Faculty of Medicine at the University of British Columbia since that time, reaching the position of Clinical Professor in 1997. At present, he is a Clinical Professor in the Department of Medicine, Division of Medical Oncology, at the University of British Columbia and the Chair of the Lymphoma Tumour Group for the B.C. Cancer Agency. Dr. Connors’ clinical activities and research efforts are focused in the area of lymphoid cancers. He is best known for his clinical investigations into the treatment of Hodgkin lymphoma, non-Hodgkin lymphoma, chronic lymphocytic leukemia, and multiple myeloma.
Dr. Julie Stakiw MD, FRCPC
Saskatchewan Cancer Agency
University of Saskatchewan
Dr. Stakiw completed her medical degree and Internal Medicine training at the University of Saskatchewan. She then moved to Ontario to complete her Hematology training at Queen’s University, followed by a one-year fellowship at The Princess Margaret Cancer Centre in Lymphoma and Stem Cell Transplant. After three years working as a hematologist-oncologist at Peel Regional Cancer Centre in Mississauga, Ontario, she moved back to Saskatchewan in 2010 and later became the Provincial Leader of Hematology for Saskatchewan and Medical Director of the Provincial Blood and Marrow Transplant Program. She is now a hematologist and the Medical Director of patient research, innovation, and analytics at the Saskatchewan Cancer Agency.
Dr. Debra Bergstrom MD, FRCPC
Memorial University of Newfoundland
St. John’s, NL
Dr. Bergstrom finished her medical degree at the University of Alberta and her residency at the Memorial University of Newfoundland. She then returned to the University of Alberta to complete her fellowship. Dr. Bergstrom has worked as a staff physician in St. John’s since finishing her fellowship. She is currently a clinical hematologist with a cross-appointment to laboratory medicine. Dr. Bergstrom also serves as an Assistant Professor of Medicine at the Memorial University of Newfoundland. In addition, she is the Medical Director of the Laboratory Stem Cell Program and the hematology curriculum lead at the university. Dr. Bergstrom’s main disease interest is malignant hematology, with a focus on plasma cell neoplasms. Her research interests include multiple myeloma, laboratory utilization, and medical education.
Dr. Elie Kassouf MD, MSc
Hematologist and Medical Oncologist
Centre hospitalier de l’Université de Montréal
Dr. Kassouf completed medical school and an internal medicine specialty at Saint Joseph University in Beirut, Lebanon. He then went to France to complete a fellowship in Hematology and Medical Oncology at Gustave Roussy Cancer Center, Université Paris-Sud. Interested by the evolution of lung cancer treatment, he undertook a fellowship in thoracic oncology at the Centre Hospitalier de l’Université de Montréal. On a more academic level, he holds a Masters of Science in advanced oncology from Ulm University in Germany, and is currently pursuing a leadership degree at McGill University in Montreal, Canada. Dr. Kassouf is currently a hematologist and medical oncologist at the Centre Hospitalier Regional De Lanaudière. Highly motivated, compassionate, and determined to improve cancer care, his current main interest revolves around optimizing resources for patients and development of clinical research in underserved areas.
Dr. Philip Kuruvilla MD, FRCPC
William Osler Health System
Assistant Clinical Professor
Dr. Kuruvilla is a Medical Oncologist at the William Osler Health System and an Assistant Clinical Professor (adjunct) at McMaster University. He completed his medical degree at the University of Toronto in 1986, his internship and residency in internal medicine and medical oncology in 1990, and his fellowship at the Princess Margaret Hospital in 1992.
Dr. Kuruvilla is a member of the Royal College of Physicians and Surgeons of Canada, the Ontario Medical Association, the American Society of Hematology, the American Society of Oncology, and the Canadian Medical Association.
Dr. Michael Chu MD, FRCPC
Cross Cancer Institute
Dr. Chu is a Clinician Scientist at the Cross Cancer Institute. He completed his medical degree, residency, and Medical Oncology Fellowship at the University of Alberta. His clinical focus includes lymphoma, myeloma, and central nervous system malignancies. Academically, his research focuses on basic and translational cancer research with an emphasis on immune therapy. Dr. Chu also serves as principal investigator and sub-principal investigator on multiple phase I, II, and III clinical trials.